Investment Stage

Focus Areas

About Investor

David Berry serves as General Partner at Flagship Ventures, focusing on investments in agtech, climate tech/clean tech, biotech, and health & hospital services sectors. He typically invests at the pre-seed and seed stages with a focus on the Boston/New England area. Berry joined Flagship in 2005 and focuses on innovating, entrepreneuring, and investing in new businesses in life sciences and sustainability. He has been involved in numerous investments including Axcella, KSQ Therapeutics, Joule Unlimited Technologies, Seres Therapeutics, Avedro, and LS9, demonstrating his deep expertise in the life sciences and sustainability sectors.